Optimi Health Corp（OPTH）の財務OPTHOptimi Health Corp

Evaluating the bottom line, Optimi Health Corp maintains a gross margin of -116.43%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -1522.61%, while the net margin is -1715.00%. These profitability ratios, combined with a Return on Equity (ROE) of -54.36%, provide a clear picture of how effectively OPTH converts its operational activities into shareholder value.

In the context of the broader market, OPTH competes directly with industry leaders such as OMEX and SEED. With a market capitalization of $13.29M, it holds a significant position in the sector. When comparing efficiency, OPTH's gross margin of -116.43% stands against OMEX's -0.44% and SEED's 11.19%. Such benchmarking helps identify whether Optimi Health Corp is trading at a premium or discount relative to its financial performance.

Optimi Health has been experiencing substantial financial difficulties, with a net income loss of -2,404,430 CAD in Q3 2026 and a gross margin of -116.43%. The total revenue for Q3 2026 was 140,200 CAD, which is insufficient to cover its expenses, leading to negative earnings per share (EPS) of -16.79.